News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,705 Results
Type
Article (55409)
Company Profile (177)
Press Release (639113)
Multimedia
Podcasts (213)
Webinars (25)
Section
Business (212407)
Career Advice (2869)
Deals (34007)
Drug Delivery (216)
Drug Development (79987)
Employer Resources (184)
FDA (16241)
Job Trends (14983)
News (321342)
Policy (31451)
Tag
2026 Best Places to Work (1)
2027 BioCapital Elite (1)
2027 BioCapital Standard (3)
2027 BioMidwest Digital (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (3)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (5)
2027 Genetown Digital (1)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (10)
2027 NextGen (2)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (10)
40 Under 40 (2)
Academia (2980)
Academic (1)
Accelerated approval (75)
ADA (53)
Adcomms (43)
Allergies (221)
Alliances (46593)
ALS (281)
Alzheimer's disease (2080)
Antibody-drug conjugate (ADC) (748)
Approvals (16820)
Artificial intelligence (973)
ASCO (342)
Autoimmune disease (489)
Automation (74)
Bankruptcy (343)
Belgium (35)
Best Places to Work (11693)
BIO (73)
Biologics (89)
BIOSECURE Act (23)
Biosimilars (287)
BioSpace Insights (183)
Biotechnology (138)
Bispecific (45)
Bladder cancer (237)
Brain cancer (99)
Breast cancer (945)
Cancer (7712)
Cardiovascular disease (638)
Career advice (2465)
Career pathing (63)
CAR-T (445)
CDC (79)
CDMO (220)
Celiac Disease (6)
Cell-line development (2)
Cell therapy (1175)
Cervical cancer (64)
Clinical research (71204)
Collaboration (2717)
Commercialization (57)
Company closure (9)
Compensation (1849)
Complete response letters (120)
COVID-19 (3004)
CRISPR (141)
CRO (3)
C-suite (1676)
Cystic fibrosis (180)
Data (10506)
Decentralized trials (4)
Denatured (62)
Depression (218)
Dermatology (190)
Diabetes (802)
Diagnostics (7317)
Digital health (72)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (492)
Drug pricing (240)
Drug shortages (40)
Duchenne muscular dystrophy (376)
Earnings (71884)
Editorial (84)
Employer branding (25)
Employer resources (172)
ESMO (425)
Events (101083)
Executive appointments (1370)
Eye disease (16)
FDA (21077)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (28)
Frontotemporal dementia (42)
Funding (2233)
Gene editing (305)
Generative AI (87)
Gene therapy (933)
GLP-1 (1337)
Government (5134)
Grass and pollen (7)
Guidances (436)
Healthcare (19561)
Hematology (200)
HIV (119)
Huntington's disease (89)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (154)
Immunology and inflammation (414)
Immuno-oncology (157)
Indications (285)
Infectious disease (3445)
Inflammatory bowel disease (277)
Inflation Reduction Act (17)
Influenza (161)
Intellectual property (374)
Interviews (536)
IPO (16297)
IRA (58)
Job creations (3541)
Job search strategy (2002)
JPM (71)
Kidney cancer (31)
Kidney disease (164)
Labor market (123)
Layoffs (696)
Leadership (68)
Legal (6866)
Licensing (100)
Liver cancer (117)
Longevity (53)
Lung cancer (1068)
Lung diease (21)
Lymphoma (536)
Machine learning (74)
Management (68)
Manufacturing (1522)
Marketing (33)
MASH (245)
Medical affairs (5)
Medical device (13407)
Medtech (13685)
Mergers & acquisitions (19226)
Metabolic disorders (2036)
Middle East (1)
mRNA (327)
Multiple sclerosis (252)
Multispecific (6)
NASH (24)
Netherlands (31)
Neurodegenerative disease (603)
Neuropsychiatric disorders (146)
Neuroscience (4169)
Neurotech (3)
NextGen: Class of 2026 (6833)
Non-profit (4741)
Now hiring (78)
Obesity (958)
Opinion (392)
Ovarian cancer (290)
Pain (340)
Pancreatic cancer (445)
Parkinson's disease (469)
Partnered (43)
Patents (774)
Patient advocacy (5)
Patient recruitment (964)
Patient selection (99)
Peanut (72)
People (64376)
Peptides (31)
Pharmaceutical (30)
Pharmacy benefit managers (41)
Phase 1 (22222)
Phase 2 (31329)
Phase 3 (23709)
Pipeline (13537)
Policy (408)
Postmarket research (2354)
Preclinical (9406)
Press Release (70)
Prostate cancer (395)
Psychedelics (91)
Radioligand (2)
Radiopharmaceuticals (430)
Rare diseases (1542)
Real estate (5518)
Recruiting (80)
Regenerative medicine (28)
Regulatory (26730)
Reports (61)
Research institute (2682)
Resumes & cover letters (456)
Rett syndrome (59)
RNA editing (37)
RSV (102)
Saudi Arabia (1)
Schizophrenia (220)
Series A (388)
Series B (274)
Service/supplier (4)
Sickle cell disease (139)
Special edition (34)
Spinal muscular atrophy (196)
Sponsored (58)
Startups (3642)
State (2)
Stem cells (7)
Stomach cancer (23)
Substance use disorders (22)
Supply chain (159)
Switzerland (11)
Tariffs (101)
Tax incentives (1)
The Weekly (148)
Vaccines (1388)
Venture capital (167)
Weight loss (644)
Wet AMD (6)
Women's health (177)
Women in leadership (1)
Worklife (28)
Date
Today (85)
Last 7 days (734)
Last 30 days (2843)
Last 365 days (31220)
2026 (26238)
2025 (30307)
2024 (35028)
2023 (39662)
2022 (50699)
2021 (55033)
2020 (53795)
2019 (47166)
2018 (35794)
2017 (32694)
2016 (31454)
2015 (36254)
2014 (27708)
2013 (22880)
2012 (24218)
2011 (24850)
2010 (21777)
Location
Africa (920)
Alabama (112)
Alaska (7)
Arizona (354)
Arkansas (15)
Asia (41861)
Australia (7331)
California (15710)
Canada (4382)
China (1957)
Colorado (658)
Connecticut (702)
Delaware (505)
Europe (97118)
Florida (2391)
Georgia (501)
Hawaii (4)
Idaho (63)
Illinois (1273)
India (138)
Indiana (730)
Iowa (34)
Japan (739)
Kansas (147)
Kentucky (55)
Louisiana (63)
Maine (73)
Maryland (1798)
Massachusetts (11250)
Michigan (387)
Minnesota (789)
Mississippi (7)
Missouri (163)
Montana (35)
Nebraska (27)
Nevada (184)
New Hampshire (87)
New Jersey (4117)
New Mexico (33)
New York (4081)
North Carolina (1945)
North Dakota (13)
Northern California (8068)
Ohio (471)
Oklahoma (22)
Oregon (49)
Pennsylvania (3005)
Puerto Rico (37)
Rhode Island (59)
South America (1225)
South Carolina (100)
South Dakota (2)
Southern California (6304)
Tennessee (259)
Texas (2624)
United States (55076)
Utah (488)
Vermont (2)
Virginia (407)
Washington D.C. (80)
Washington State (1249)
West Virginia (4)
Wisconsin (179)
Wyoming (6)
694,705 Results for "ampliphi biosciences formerly known as targeted genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Setara Biosciences Announces $90 Million Series A Financing to Advance Precision Medicines for Rare Genetic Diseases and Related Expansion Indications
October 30, 2026
·
6 min read
Press Releases
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
October 28, 2026
·
6 min read
ALS
Biogen’s targeted ALS treatment is reversing decline in some patients. Can more be helped?
Three years after Qalsody was approved by the FDA as the first drug to target a genetic cause of ALS, some patients are reporting not only disease stabilization but also improvement of symptoms.
August 10, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations
October 29, 2026
·
6 min read
Press Releases
Hummingbird Bioscience Appoints Dr. James Garner as President
September 15, 2026
·
3 min read
Press Releases
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington’s Disease Franchise
October 14, 2026
·
6 min read
Press Releases
Baylor Genetics Selected as the Lead Sequencing Partner for Florida’s Sunshine Genetics Pilot Program Launch
October 5, 2026
·
3 min read
ALS
Ionis-Otsuka offer ‘groundbreaking’ improvement in function and survival for genetic type of ALS
Ulefnersen, an RNA-targeted therapy being developed by Ionis Pharmaceuticals and Otsuka Pharmaceutical, improved measurements of functional impairment and survival in patients with a rare, genetic ALS subtype in a Phase 3 trial. The partners plan to approach the FDA with the results to determine potential pathways for approval.
September 23, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
October 5, 2026
·
3 min read
Press Releases
Chipscreen Biosciences Announces NMPA IND Approval for NW001, a PD-L1-Targeted Epigenetic Immune-Modulating Antibody Conjugate
October 18, 2026
·
4 min read
1 of 69,471
Next
